PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
16-Nov-2022 PAION AG reports financial results for the first nine months of 2022 PAION AG
16-Nov-2022 Dermapharm Holding SE successfully maintains growth trend as planned Dermapharm Holding SE
16-Nov-2022 PharmaSGP posts record revenues (+39%) and record earnings (+54%) in 9M 2022 – raises full-year forecast PharmaSGP Holding SE
16-Nov-2022 Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
16-Nov-2022 Kinarus Therapeutics Engages Great Health Companion Group to Explore Partnerships in China Kinarus Therapeutics Holding AG
15-Nov-2022 Expansion of the Management Board of M1 Kliniken AG M1 Kliniken AG
15-Nov-2022 Abivax releases the results of its November 9, 2022 ad hoc ordinary and extraordinary general meeting ABIVAX
15-Nov-2022 PAION AG raises EBITDA forecast for fiscal year 2022 PAION AG
15-Nov-2022 Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe Avanzanite Bioscience
15-Nov-2022 ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro ImmunOs Therapeutics
15-Nov-2022 HUTCHMED Announces Strategy to Focus on Late-Stage Pipeline Regulatory Approvals HUTCHMED
15-Nov-2022 Domainex expands Executive and Management Teams to support ongoing growth Sciad Newswire
15-Nov-2022 Medacta Group SA announces the final settlement in the Conformis case Medacta Group SA
15-Nov-2022 Healthcare and Medical Leaders Gather to Shape the Future of Global Health HKTDC
14-Nov-2022 MagForce AG: Agreement in principle on the sale of business operations MagForce AG
14-Nov-2022 PAION AG’S PARTNER TTY BIOPHARM RECEIVES MARKET APPROVAL FOR REMIMAZOLAM IN PROCEDURAL SEDATION IN TAIWAN PAION AG
14-Nov-2022 EVERSANA® Names Experienced Life Sciences Leader Sy Pretorius Chief Operating Officer & President, Outsourced Solutions to Propel Next-Generation Commercialization Services Worldwide EVERSANA®
14-Nov-2022 EpiEndo Commences Phase 2a Trial for EP395 in COPD Patients EpiEndo
14-Nov-2022 Luforbec® 200/6 (beclometasone 200mcg / formoterol 6mcg) a certified carbon neutral inhaler is launched in the UK for the treatment of adult asthma Lupin Healthcare UK
14-Nov-2022 EpiEndo Commences Phase 2a Trial for EP395 in COPD Patients B3C newswire